| Test Id | Test Name | TAT (Days) | Quantity | |
|---|---|---|---|---|
| 2250 | 12q13 | Tat: 3 Days | View More | |
| 1515 | 17 – Alpha- Hydroxy Progesterone | Tat: 2 Days | View More | |
| 2243 | 17p (p53) – CLL, MM | Tat: 3 Days | View More | |
| 2251 | 1p & 19q codeletion | Tat: 3 Days | View More | |
| 1102 | 24 Hrs Urinary Cortisol/Creatinine Ratio | Tat: 2 Days | View More | |
| 2252 | 6q21 | Tat: 3 Days | View More | |
| TG-06 | ABO-Rh Molecular Typing | Tat: 15 Days | View More | |
| 1536 | ACHR Binding Antibody | Tat: 2 Days | View More | |
| 1101 | Acid Phosphatase – Prostatic (PAP) | Tat: 3 Days | View More | |
| 1103 | Acid Phosphatase – Total | Tat: 2 Days | View More | |
| 1501 | ACTH | Tat: 2 Days | View More | |
| 1605 | Activated Partial Thromboplastin Time (aPTT) | Tat: 1 Day | View More | |
| 1106 | Adenosine Deaminase (ADA) | Tat: 2 Days | View More | |
| ADVANCED PROFILE HEALTH PACKAGE | Tat: | View More | ||
| 1529 | AFP | Tat: 2 Days | View More | |
| 1108 | Albumin | Tat: 2 Days | View More | |
| 1109 | Albumin/Creatinine Ratio | Tat: 2 Days | View More | |
| 1104 | Alcohol | Tat: 2 Days | View More | |
| 1105 | Aldolase | Tat: 2 Days | View More | |
| 1112 | Alkaline Phosphatase (ALP) | Tat: 2 Days | View More | |
| 2311 | ALL Panel (BCR/ABL, TEL/AML1, MLL) | Tat: 8 Days | View More | |
| 4122 | Alpha Thalassemia Mutation Study | Tat: 15 Days | View More | |
| 4532 | AML – FLT3 MUTATION PCR (ITD & D835) | Tat: 6 Days | View More | |
| 2314 | AML Panel (AML/ETO, inv16, PML/RARA, MLL) | Tat: 8 Days | View More | |
| 4533 | AML-NPM1 Mutation Analysis | Tat: 6 Days | View More | |
| 4531 | AML/ETO Qualitative PCR | Tat: 6 Days | View More | |
| 1113 | Amylase | Tat: 2 Days | View More | |
| 1538 | ANCA Titre | Tat: 2 Days | View More | |
| 2020 | Aneuploidy 13, 18, 21, X, Y (POC) | Tat: 5 Days | View More | |
| 2010A | Aneuploidy 13, 18, 21, X, Y (Postnatal) | Tat: 3 Days | View More | |
| 2010C | Aneuploidy 13, 18, 21, X, Y (Prenatal) – CVS | Tat: 3 Days | View More | |
| 2010 | Aneuploidy 13, 18, 21, X, Y (Prenatal) -Amnio | Tat: 3 Days | View More | |
| 2011 | Aneuploidy 13, 18, 21, X, Y Plus Culture | Tat: 3,20 Days | View More | |
| 2012A | Aneuploidy 13, 21 (Postnatal) | Tat: 3 Days | View More | |
| 2012 | Aneuploidy 13, 21 (Prenatal) | Tat: 3 Days | View More | |
| 2013A | Aneuploidy 18, X, Y (Postnatal) | Tat: 3 Days | View More | |
| 2013 | Aneuploidy 18, X, Y (Prenatal) | Tat: 3 Days | View More | |
| 1114 | Angiotensin Converting Enzyme (ACE) | Tat: 2 Days | View More | |
| 4081 | Angleman Syndrome | Tat: 10 Days | View More | |
| Assure - 03 | Antenatal – Profile Glucose – Random, Complete Urine Analysis, Blood Grouping (A,B,O) and RH Factor, Complete Blood Count (CBC), TSH (Thyroid Stimulating Hormone), Hepatitis B Surface antigen (HBsAg)-Rapid, HIV 1 & 2 Antibody- Rapid, HCV Rapid ,Plasma Reagin (RPR Test) | Tat: 1 Day | View More | |
| 1437 | Anti HBS Ab | Tat: 2 Days | View More | |
| 1518 | Anti Mullerian Hormone (AMH) | Tat: 2 Days | View More | |
| 1539 | Anti Nuclear Antibody (ANA) | Tat: 2 Days | View More | |
| 1540 | Anti Phospholipid IgG+IgM | Tat: 2 Days | View More | |
| 1519 | Anti TG | Tat: 2 Days | View More | |
| Assure - 04 | Anti Thyroid Antibody Panel – Antithyroglobulin Antibodies (ATG) Anti TPO (Anti Thyroperoxidase/ Microsomal Antibodies) | Tat: 2 Days | View More | |
| 1520 | Anti TPO | Tat: 2 Days | View More | |
| 1537 | Anti-CCP | Tat: 2 Days | View More | |
| Assure - 06 | Arthritis Panel – Alkaline Phosphatase(ALP), Anti Nuclear Antibody, Rheumatoid Factor, RA, Anti Streptolysin O (ASO) (Rapid), C4 Complement, C Reactive Protein (CRP), Uric Acid – Serum,C3 Complement | Tat: 3 Days | View More | |
| Assure - 02 | Assure Advanced Profile – Complete Blood Count (CBC), Erythrocyte Sedimentation Rate (ESR), Lipid Profile,Thyroid Profile, Glycosylated hemoglobin (HbA1c), Kidney Profile, Liver Function Test (LFT), Vitamin- B12 (cyanocobalamin), 25 – Hydroxy Vitamin D, Glucose Fasting (F) | Tat: 1 Day | View More | |
| Assure - 01 | Assure Basic Profile – Complete Blood Count (CBC) , Erythrocyte Sedimentation Rate (ESR), Lipid Profile, Thyroid Profile, Glucose Fasting (F), Kidney Profile, Liver Function Test (LFT), | Tat: 1 Day | View More | |
| 2236 | ATM (11q22.3) – CLL | Tat: 3 Days | View More | |
| Assure - 05 | Autoimmune Hepatitis Panel – Anti Nuclear Antibody, Liver-Kidney Microsome – 1 Antibody (LKM 1), Anti Mitochondrial Antibody, Anti Smooth Muscle Antibody – (Qualitative) | Tat: 3 Days | View More | |
| Assure - 07 | Bad Obstertics History (BOH)- Cardiolipin Antibody, IgG, Phospholipid Antibody IgG, TSH (Thyroid Stimulating Hormone), Anti Nuclear Antibody, Lupus Anticoagulant, TORCH 10 Profile (IgG & IgM) | Tat: 1 Day | View More | |
| BASIC PROFILE HEALTH PACKAGE | Tat: | View More | ||
| 2230 | BCL6 (3q22) – MALT | Tat: 3 Days | View More | |
| 4513 | BCR/ABL IRMA | Tat: 15 Days | View More | |
| 4514 | BCR/ABL Kinase Mutation | Tat: 21 Days | View More | |
| 4511 | BCR/ABL PCR Qualitative | Tat: 3 Days | View More | |
| 4512 | BCR/ABL PCR Quantiative | Tat: 3 Days | View More | |
| 2211 | BCR/ABL1 t(9;22) – CML, ALL, AML-M1 | Tat: 3 Days | View More | |
| 4125 | Beta Thalassemia Mutation (Parents + Child) | Tat: 14 Days | View More | |
| 4123 | Beta Thalassemia Mutation Study (Individual) | Tat: 15 Days | View More | |
| 4124 | Beta Thalassemia Mutation Study (Parents) | Tat: 15 Days | View More | |
| 4126 | Beta Thalassemia Prenatal Diagnosis | Tat: 15 Days | View More | |
| 1117 | Bilirubin – Indirect | Tat: 2 Days | View More | |
| 1118 | Bilirubin (Total + Direct) | Tat: 2 Days | View More | |
| NBS-01 | Bio5 (CH,CAH,G6PD, Galactosemia, Biotinidase) | Tat: 6 Days | View More | |
| NBS-02 | Bio7 (Cystic Fibrosis, PKU, Bio5) | Tat: 6 Days | View More | |
| 6035 | BK Virus Quantitative PCR (BKV VIRAL LOAD) | Tat: 5 Days | View More | |
| 1607 | Blood Grouping | Tat: 1 Day | View More | |
| 1119 | Blood Urea Nitrogen (BUN) | Tat: 2 Days | View More | |
| HP09 | Bone Marrow Aspirate | Tat: 3 Days | View More | |
| HP07 | Bone Marrow Biopsy | Tat: 3 Days | View More | |
| 4561 | BRAF – Colorectal Cancer | Tat: 7 Days | View More | |
| 2111 | Breast Cancer: Her-2/neu | Tat: 8 Days | View More | |
| 1502 | C Peptide | Tat: 2 Days | View More | |
| 4535 | c-KIT (Exons 9,11,13,17) (AML/GIST) | Tat: 5 Days | View More | |
| 1533 | C-Reactive Protien (CRP) | Tat: 2 Days | View More | |
| 1541 | CA19.9 – Pancreatic Cancer Marker | Tat: 2 Days | View More | |
| 1521 | Calcitonin | Tat: 2 Days | View More | |
| 1120 | Calcium | Tat: 2 Days | View More | |
| 1121 | Calcium – Spot | Tat: 2 Days | View More | |
| 1122 | Calcium/Creatinine – Ratio | Tat: 2 Days | View More | |
| Assure - 10 | Cancer Profile – Female – Complete Blood Count (CBC), Beta Human Chorionic Gonadotropin – Serum, CA19.9 – Pancreatic Cancer Marker, CA15.3 – Breast Cancer Marker Carcino Embryonic Antigen (CEA), Alpha FetoProtein (AFP) CA125 – Ovarian Cancer Marker | Tat: 1 Day | View More | |
| Assure - 09 | Cancer Profile – Male – Beta Human Chorionic Gonadotropin – Serum, Carcino Embryonic Antigen (CEA), Prostate-specific Antigen (PSA), Alpha FetoProtein (AFP), CA19.9 – Pancreatic Cancer Marker, Complete Blood Count (CBC) | Tat: 1 Day | View More | |
| IHC-136 | Carcinoids | Tat: 5 Days | View More | |
| Assure - 11 | Cardiac Profile – Creatine PhosphoKinase (CPK) Creatine Kinase (CK), MB, Lactate Dehydrogenase (LDH) – Serum, Aspartate Aminotransferase (AST/SGOT) | Tat: 1 Day | View More | |
| Assure - 08 | Cardiolipin Profile – Cardiolipin IgA, IgG, IgM Antibody | Tat: 1 Day | View More | |
| 2242 | CBFB (Inv16) – AML-M4Eo | Tat: 3 Days | View More | |
| 2237 | CCND1(11q13) – MM | Tat: 3 Days | View More | |
| 2217 | CCND1/IGH t(11;14) – MCL, MM | Tat: 3 Days | View More | |
| TG-04 | CCR5Δ32 Detection -Molecular Method | Tat: 15 Days | View More | |
| 1442 | Chikunguniya IgG/IgM Rapid Card | Tat: 1 Day | View More | |
| 6039 | Chikungunya PCR | Tat: 2 Days | View More | |
| 6041 | Chlamydia trachomatis PCR | Tat: 5 Days | View More | |
| 1123 | Cholesterol – HDL | Tat: 2 Days | View More | |
| 1124 | Cholesterol – LDL | Tat: 2 Days | View More | |
| 1125 | Cholesterol – Total | Tat: 2 Days | View More | |
| 1126 | Cholinesterase | Tat: 3 Days | View More | |
| 1070 | Chromosomal Breakage Study | Tat: 20 Days | View More | |
| 1528 | CK-MB | Tat: 2 Days | View More | |
| 2312 | CLL Panel (11q ATM, trisomy 12, de13q, del17p) | Tat: 8 Days | View More | |
| 3020 | CMA (HD) + Karyotype (Amnio/CVS) | Tat: 20 Days | View More | |
| 3220 | CMA (LD) + Karyotype (Amnio/CVS) | Tat: 20 Days | View More | |
| 3330 | CMA (ULD) + Karyotype (Amnio/CVS) | Tat: 20 Days | View More | |
| 3022 | CMA in Amniotic Fluid (HD) | Tat: 20 Days | View More | |
| 3222 | CMA in Amniotic Fluid (LD) | Tat: 15 Days | View More | |
| 3322 | CMA in Amniotic Fluid (ULD) | Tat: 15 Days | View More | |
| 3023 | CMA in Chorionic Villus Sample (HD) | Tat: 20 Days | View More | |
| 3223 | CMA in Chorionic Villus Sample (LD) | Tat: 15 Days | View More | |
| 3323 | CMA in Chorionic Villus Sample (ULD) | Tat: 15 Days | View More | |
| 3015 | CMA in Peripheral Blood (HD) | Tat: 30 Days | View More | |
| 3215 | CMA in Peripheral Blood (LD) | Tat: 20 Days | View More | |
| 3315 | CMA in Peripheral Blood (ULD) | Tat: 20 Days | View More | |
| 3026 | CMA in Products of Conception (HD) | Tat: 30 Days | View More | |
| 3226 | CMA in Products of Conception (LD) | Tat: 20 Days | View More | |
| 3326 | CMA in Products of Conception (ULD) | Tat: 20 Days | View More | |
| 2315 | CML Panel (Cyto + BCR/ABL) | Tat: 8 Days | View More | |
| TG-05 | CMV IgG testing – Molecular Method | Tat: 10 Days | View More | |
| Assure - 13 | Coagulation Profile – PT, APTT, Platelets Count | Tat: 1 Day | View More | |
| 1601 | Complete Blood Count (CBC) | Tat: 1 Day | View More | |
| 1602 | Complete Blood Count (CBC) – with ESR | Tat: 1 Day | View More | |
| Assure - 12 | Complete Blood Profile – Complete Blood Count (CBC), Erythrocyte Sedimentation Rate (ESR), Peripheral Smear and Examination | Tat: 2 Days | View More | |
| 1127 | Copper – Serum | Tat: 3 Days | View More | |
| 1128 | Copper – Urine | Tat: 3 Days | View More | |
| 1503 | Cortisol II | Tat: 2 Days | View More | |
| 6045 | COVID 19 – SARS-COV-2 PCR (Delhi) | Tat: 1-2 Days | View More | |
| 6045-1 | COVID 19 – SARS-COV-2 PCR (UP) | Tat: 1-2 Days | View More | |
| 1401 | Covid 19 Antibody IgG | Tat: 2 Days | View More | |
| 1435 | Covid 19 Antibody IgG Spike Protien | Tat: 2 Days | View More | |
| 1401A | Covid 19 Antibody IgM | Tat: 2 Days | View More | |
| 1402 | Covid 19 Antibody Total | Tat: 2 Days | View More | |
| 1436 | Covid 19 Rapid Antigen | Tat: 2 Days | View More | |
| Covid Checkup | COVID Check Up Profile | Tat: 1-2 Days | View More | |
| Covid Plus | COVID Plus Profile | Tat: 1-2 Days | View More | |
| COVID-19 Antibody IgG Spike Protien | Tat: 1 Day | View More | ||
| COVID-19 Rapid Antigen | Tat: 1 Day | View More | ||
| 1129 | Creatine Kinase MB (CK-MB) | Tat: 2 Days | View More | |
| 1130 | Creatinine | Tat: 2 Days | View More | |
| 1131 | Creatinine – Spot | Tat: 2 Days | View More | |
| 1132 | Creatinine Clearence Test | Tat: 2 Days | View More | |
| 1133 | Creatinine PhosphoKinase (CPK) | Tat: 2 Days | View More | |
| MB-02 | Culture & Sensitivity (Pus, Urine, BAL, Swab) | Tat: 4 Days | View More | |
| MB-01 | Culture & Sensitivity Blood (Aerobic) | Tat: 4 Days | View More | |
| 4041 | Cystic Fibrosis – Delta 508 Mutation | Tat: 15 Days | View More | |
| 1426 | Cytomegalo Virus IgG | Tat: 2 Days | View More | |
| 1425 | Cytomegalo Virus IgM | Tat: 2 Days | View More | |
| 6011 | Cytomegalovirus Qualitative PCR | Tat: 3 Days | View More | |
| 6010 | Cytomegalovirus Quantitative PCR (CMV VIRAL LOAD) | Tat: 3 Days | View More | |
| 1542 | D-dimer | Tat: 2 Days | View More | |
| IHC-161 | D/d Prostate VsUrothelial Carcinoma | Tat: 5 Days | View More | |
| 1514 | Dehydroepiandrosterone | Tat: 2 Days | View More | |
| 2239 | Del 13q – CLL, MM | Tat: 3 Days | View More | |
| 2249 | Del 13q14- Retinoblastoma | Tat: 3 Days | View More | |
| 2248 | Del 13q14.3-del 13q34- CLL | Tat: 3 Days | View More | |
| 2246 | Del 20q – MDS | Tat: 3 Days | View More | |
| 2232 | Del 7q – MDS | Tat: 3 Days | View More | |
| 1430 | Dengue IgM Antibody – ELISA | Tat: 2 Days | View More | |
| 1543 | Dengue NS1 Antigen | Tat: 2 Days | View More | |
| 1431 | Dengue NS1 Antigen – ELISA | Tat: 2 Days | View More | |
| 6038 | Dengue PCR | Tat: 2 Days | View More | |
| Assure - 14 | Dengue Profile Rapid – Dengue IgG, IgM and NS1 Ag | Tat: 1 Day | View More | |
| 1504 | DHEAS | Tat: 2 Days | View More | |
| 2015 | DiGeorge/ Velocardiofacial | Tat: 5 Days | View More | |
| 1512 | Dihydrotestosterone (DHT) | Tat: 2 Days | View More | |
| 7018 | Double Marker + PLGF | Tat: 5 Days | View More | |
| 7011 | Double Marker/First Timester – PAPP-A, Free B HCG (Roche) | Tat: 2 Days | View More | |
| IHC-141 | DSRCT | Tat: 5 Days | View More | |
| 4551 | EGFR Mutation (4 exons) | Tat: 7 Days | View More | |
| 1136 | eGlomerular Filtration Rate (eGFR) | Tat: 2 Days | View More | |
| 2231 | EGR1 (del 5q) – MDS | Tat: 3 Days | View More | |
| 1302 | Electrolyte Profile ( Sodium, Potassium, Chloride,Ionic Calcium) | Tat: 1 Day | View More | |
| IHC-132 | Endocervical Adenocarcinoma | Tat: 5 Days | View More | |
| IHC-133 | Endometrial Carcinoma | Tat: 5 Days | View More | |
| TG-07 | Engraftment Monitoring | Tat: 15 Days | View More | |
| 6012 | Epstein-Barr virus (EBV) Qualtiative PCR | Tat: 5 Days | View More | |
| 6013 | Epstein-Barr virus (EBV) Quantiative PCR | Tat: 5 Days | View More | |
| 1505 | Estradiol III | Tat: 2 Days | View More | |
| 2213 | ETO/AML t(8;12) – AML-M2 | Tat: 3 Days | View More | |
| 1546 | Everolimus | Tat: 2 Days | View More | |
| IHC-121 | Extended B-Cell Lymphoma Marker | Tat: 5 Days | View More | |
| 1531 | Ferretin | Tat: 2 Days | View More | |
| Assure - 15 | Fertility Profile – AMH , LH, FSH, PRL, E2, TSH, Testo – Total & Progesterone | Tat: 1 Day | View More | |
| Fever Molecular Extended Panel | Tat: 1 Day | View More | ||
| 6102 | Fever Molecular Extended Panel (Influenza Type A/B, RSV, H1N1, H3N2, Dengue, Chikungunya, Covid-19) | Tat: 2 Days | View More | |
| 6101 | Fever Molecular Panel (Influenza Type A/B, RSV, H1N1, H3N2) | Tat: 2 Days | View More | |
| Assure - 20 | Fever Panel Extended – Complete Urine Analysis (CUE), Malarial Falciparum and Vivax Antigen (Parasite V & F), Complete Blood Count (CBC), Erythrocyte Sedimentation Rate (ESR), Widal Test (Slide Test) | Tat: 1 Day | View More | |
| Assure - 19 | Fever Panel- Complete Blood Count (CBC), Widal Test (Slide Test), Malarial Falciparum and Vivax Antigen (Parasite V & F) | Tat: 1 Day | View More | |
| 2215 | FGFR3/IGH t(4;14) – MM | Tat: 3 Days | View More | |
| 1134 | Fluid Examination – Routine | Tat: 2 Days | View More | |
| 4046 | Fragile X in Females | Tat: 20 Days | View More | |
| 4045 | Fragile X Methylation Study | Tat: 20 Days | View More | |
| Assure - 26 | Free Thyroid Profile – FT3, FT4, FTSH | Tat: 1 Day | View More | |
| 1506 | FSH | Tat: 2 Days | View More | |
| 1522 | FT3 | Tat: 2 Days | View More | |
| 1523 | FT4 | Tat: 2 Days | View More | |
| 1135 | Gamma Glutamyl Transferase (GGT) | Tat: 2 Days | View More | |
| NBS-04 | GCMS | Tat: 6 Days | View More | |
| IHC-102 | Glioma Classification (D/d Gliosis Vs Glioma) | Tat: 5 Days | View More | |
| 1137 | Glucose – Fasting | Tat: 2 Days | View More | |
| 1138 | Glucose – PLBS | Tat: 2 Days | View More | |
| 1139 | Glucose – Random | Tat: 2 Days | View More | |
| 1140 | Glucose 6 Phosphate Dehydrogenase (G6PD) | Tat: 3 Days | View More | |
| 1141 | Glucose Challenge Test (GCT) | Tat: 2 Days | View More | |
| 1301 | Glucose F/PP ; Hb1Ac | Tat: 1 Day | View More | |
| 1603 | HB1Ac | Tat: 1 Day | View More | |
| 1407 | HBc Ag | Tat: 2 Days | View More | |
| 1441 | HCV Ag | Tat: 2 Days | View More | |
| 6018-1 | HCV GENOTYPING (Copy) | Tat: 5 Days | View More | |
| 1418A | HCV IgM | Tat: 2 Days | View More | |
| 1418 | HCV Total Antibody | Tat: 2 Days | View More | |
| 1403 | Hepatitis A Virus (HAV) Antibody – IgG | Tat: 2 Days | View More | |
| 1404 | Hepatitis A Virus (HAV) IgM | Tat: 2 Days | View More | |
| 1408 | Hepatitis B Core Antibody IgM (Anti HBc – IgM) | Tat: 2 Days | View More | |
| 1409 | Hepatitis B Core Antibody Total (HBcAb- Total) | Tat: 2 Days | View More | |
| 1406 | Hepatitis B Envelope Antibody (AntiHBe) | Tat: 2 Days | View More | |
| 1405 | Hepatitis B Envelope Antigen (HBeAg) | Tat: 2 Days | View More | |
| Assure - 17 | Hepatitis B Virus (HBV) Profile | Tat: 2 Days | View More | |
| 6014 | Hepatitis B Virus (HBV) Qualitative PCR | Tat: 2 Days | View More | |
| 6015 | Hepatitis B Virus (HBV) Quantitative PCR (HBV VIRAL LOAD) | Tat: 2 Days | View More | |
| 6016 | Hepatitis C Virus (HCV) Qualitative PCR | Tat: 2 Days | View More | |
| 6017 | Hepatitis C Virus (HCV) Quantitative PCR (HCV VIRAL LOAD) | Tat: 2 Days | View More | |
| 1416 | Hepatitis E Virus (HEV) Antibody – IgG | Tat: 2 Days | View More | |
| 1417 | Hepatitis E Virus (HEV) Antibody – IgM | Tat: 2 Days | View More | |
| HEPATITIS HEALTH PACKAGE | Tat: | View More | ||
| Assure - 16 | Hepatitis Profile – Hepatitis A Virus IgM Antibody (HAV IgM), Hepatitis A Virus IgG Antibody (HAV IgG), Hepatitis B Envelope Antibody (Anti HBe), Hepatitis B Envelope Antigen (HBeAg), Hepatitis B Surface Antibody (HBsAb), Hepatitis B Surface Antigen (HBsAg)-ELISA, Hepatitis C Virus Antibody-ELISA, Hepatitis B Core Antibody (Anti HBc), IgM , Hepatitis B Core Antibody (Anti HBc), Total, Hepatitis E Virus IgM Antibody (HEV IgM) | Tat: 2 Days | View More | |
| 1411 | Hepatitis Surface Antigen (HBs Ag) | Tat: 2 Days | View More | |
| 1427 | Herpes Simplex Virus IgG | Tat: 2 Days | View More | |
| 1428 | Herpes Simplex Virus IgM | Tat: 2 Days | View More | |
| HP05 | Histopathology – (Bone) Large | Tat: 5 Days | View More | |
| HP06 | Histopathology – (Bone) Small | Tat: 4 Days | View More | |
| 1438 | HIV 1&2 Antibody | Tat: 2 Days | View More | |
| 1412 | HIV Antigen | Tat: 2 Days | View More | |
| Assure - 18 | HIV-Monitoring – CD3/CD4/CD8, HIV – 1 RNA Virus – Quantitative – Viral Load | Tat: 3 Days | View More | |
| TG-01 | HLA (A,B,C,DRB1 & DQB1) 1X – High Resolution | Tat: 15 Days | View More | |
| TG-02 | HLA (A,B,C,DRB1 & DQB1) 3X – High Resolution | Tat: 15 Days | View More | |
| 4040 | HLA-B27 PCR | Tat: 3 Days | View More | |
| 4071 | HLA-B51/52 | Tat: 8 Days | View More | |
| 4072 | HLA-B57 | Tat: 8 Days | View More | |
| IHC-124 | Hodgkins Lymphoma | Tat: 5 Days | View More | |
| 1544 | HOMOCYSTEINE | Tat: 2 Days | View More | |
| HPV-04 | HPV – LBC + Molecular Testing | Tat: 4 Days | View More | |
| HPV-03 | HPV Genotyping (16/18) | Tat: 4 Days | View More | |
| HPV-02 | HPV Molecular Screening | Tat: 4 Days | View More | |
| HPV-01 | HPV Screning using Liquid Based Cytology (LBC) | Tat: 4 Days | View More | |
| 6036 | HSV – Qualitative (Combined 1/2 sub-types) | Tat: 5 Days | View More | |
| 6022 | Human Immunodeficiency Virus (HIV) Qualitative PCR | Tat: 3 Days | View More | |
| 6020 | Human Immunodeficiency Virus Quantitative PCR (HIV VIRAL LOAD) | Tat: 3 Days | View More | |
| 2240 | IGH (14q32) – MALT, MM | Tat: 3 Days | View More | |
| 2218 | IGH/BCL2 t(14;18) – Follicular Lymphoma | Tat: 3 Days | View More | |
| 2216 | IGH/MAF t(14;16) – MM | Tat: 3 Days | View More | |
| 1532 | IL6 | Tat: 2 Days | View More | |
| Assure - 21 | Infectious (Rapid) – HIV,HCV,HBsAg | Tat: 1 Day | View More | |
| 6053 | Inflenze Type A and Type B | Tat: 2 Days | View More | |
| 1513 | Inhibin A | Tat: 2 Days | View More | |
| 1516 | INSULIN | Tat: 2 Days | View More | |
| 4534 | Inversion 16 – CBFB/MYH11 Qualitative PCR | Tat: 8 Days | View More | |
| 1144 | Iron Binding Capacity – Total (TIBC) | Tat: 2 Days | View More | |
| Assure - 22 | Iron Profile-I – Iron(Fe), Unsaturated iron binding capacity (UIBC), Total Iron Binding Capacity (TIBC), Transferrin, Iron Saturation((% Transferrin Saturation) | Tat: 1 Day | View More | |
| Assure - 23 | Iron Profile-II – Ferritin, Iron(Fe), Unsaturated iron binding capacity (UIBC), Total Iron Binding Capacity (TIBC), Transferrin, Iron Saturation (% Transferrin Saturation) | Tat: 1 Day | View More | |
| 1143 | Iron Serum | Tat: 2 Days | View More | |
| 4542 | JAK2 MUTATION PANEL (Exon 12 & 14) | Tat: 5 Days | View More | |
| 4541 | JAK2 V617F Qualitative PCR | Tat: 3 Days | View More | |
| 1060 | Karyotye – Bone Marrow | Tat: 8 Days | View More | |
| 1020 | Karyotype – Amniotic Fluid | Tat: 20 Days | View More | |
| 1010 | Karyotype – Blood | Tat: 15 Days | View More | |
| 1011 | Karyotype – Blood for Couples | Tat: 15 Days | View More | |
| 1040 | Karyotype – Cord Blood | Tat: 15 Days | View More | |
| 1030 | Karyotype – CVS | Tat: 20 Days | View More | |
| 1050 | Karyotype – Product of Conception | Tat: 20 Days | View More | |
| 1306 | Kidney Function Test (KFT) – With Electrolytes | Tat: 1 Day | View More | |
| 1303 | Kidney Function Test- KFT Extended (Urea, Creatinine, Uric acid, BUN, BUN/ Creat, Ratio, eGFR, Calcium) | Tat: 1 Day | View More | |
| TG-03 | KIR Gene Typing | Tat: 15 Days | View More | |
| 4552 | KRAS Mutation | Tat: 7 Days | View More | |
| 1145 | Lactate | Tat: 2 Days | View More | |
| 1146 | Lactate Dehyderogenase (LDH) | Tat: 2 Days | View More | |
| IHC-123 | Large B-Cell Lymphoma | Tat: 5 Days | View More | |
| HP03 | Large Biopsy ( >5 cm : Whole Organ , Uterus, Colon Breast etc) | Tat: 6 Days | View More | |
| IHC-134 | Leiomyosarcoma | Tat: 5 Days | View More | |
| 6043 | Leptospirosis PCR | Tat: 5 Days | View More | |
| 1507 | LH | Tat: 2 Days | View More | |
| 1147 | Lipase | Tat: 2 Days | View More | |
| 1305 | Lipid profile (Cholestrol, triglyceride, HDL, LDL, VLDL, Non HDL Cholesterol, LDL / HDL Ratio, HDL / LDL Ratio) | Tat: 1 Day | View More | |
| 1148 | Lipoprotein a (Lp-a) | Tat: 2 Days | View More | |
| 1304 | Liver Function Test – LFT – (Bilirubin Total, Direct, indirect, SGOT, SGPT, ALK PO4, GGT, T. Protein, Albumin, Globulin, A/G Ratio) | Tat: 1 Day | View More | |
| 2115 | Lung Cancer: ALK | Tat: 8 Days | View More | |
| 2116 | Lung Cancer: ROS1 | Tat: 8 Days | View More | |
| IHC-144 | Lymphoma | Tat: 5 Days | View More | |
| 1149 | Magnesium | Tat: 2 Days | View More | |
| 1439 | Malaria Antigen | Tat: 2 Days | View More | |
| 6104 | Malaria Panel (Dengue, Chikungunya) by PCR | Tat: 2 Days | View More | |
| 2245 | MALT1 (18q21) | Tat: 3 Days | View More | |
| 2313 | MDS Panel: (del 5q, del 7q, trisomy 8, del 20q) | Tat: 8 Days | View More | |
| HP02 | Medium Biopsy ( 2-5 cm : Gall Bladder, Lymph Nodes, etc) | Tat: 4 Days | View More | |
| IHC-101 | Melanoma | Tat: 5 Days | View More | |
| IHC-154 | Mesothelioma Markers | Tat: 5 Days | View More | |
| IHC-113 | Metastatic Breast Carcinoma | Tat: 5 Days | View More | |
| IHC-103 | Metastatic Poorly Differentiated Carcinoma | Tat: 5 Days | View More | |
| 2235 | MLL (11q23) – ALL, AML – M4,M5 | Tat: 3 Days | View More | |
| 2316A | MM Panel -2 – del17p, del13q, t(4,14), t(11,14) | Tat: 8 Days | View More | |
| IHC-112 | Molecular Classification Breast Carcinoma | Tat: 5 Days | View More | |
| 4564 | MPN Panel (CALR, MPL, JAK2, BCR-ABL) | Tat: 7 Days | View More | |
| 6033 | MTB MDR DRUG RESISTANCE PCR | Tat: 2 Days | View More | |
| 6033-1 | MTB MDR DRUG RESISTANCE PCR (Copy) | Tat: 2 Days | View More | |
| 6032C | MTB PCR for Tissue Sample | Tat: 3 Days | View More | |
| 6103 | Mucormycosis Panel (Rhizopus, Mucor, Rhizomucor,Lichtheimia,Cunninghamella species) | Tat: 2 Days | View More | |
| 2316 | Multiple Myeloma (MM) Panel (CCND1/IGH, del13q, IGH/MAF, del17p, FGFR3/IGH) | Tat: 8 Days | View More | |
| 2234 | MYC (8q24) – Burkitt Lymphoma | Tat: 3 Days | View More | |
| 2219 | MYC/IGH t(8;14) – Burkitt Lymphoma | Tat: 3 Days | View More | |
| 6032A | Mycobacterium Tuberculosis (MTB) DNA PCR | Tat: 2 Days | View More | |
| 6042 | Neisseria Gonorrhoeae PCR | Tat: 5 Days | View More | |
| IHC-145 | Nephroblastoma | Tat: 5 Days | View More | |
| IHC-142 | Neuroblastoma | Tat: 5 Days | View More | |
| 7031 | NIPS – T12,18,21, SCA – Assurety | Tat: 15 Days | View More | |
| 7032 | NIPS – T13,18,21, SCA – Harmony | Tat: 15 Days | View More | |
| 4563 | NRAS Mutation Analysis | Tat: 7 Days | View More | |
| IHC-152 | NSCLC | Tat: 5 Days | View More | |
| 6032B | NTM/MTB (MOTT) PCR | Tat: 2 Days | View More | |
| IHC-143 | Olfactory Neuroblastoma | Tat: 5 Days | View More | |
| 1150 | Osmatic Fragility Test | Tat: 3 Days | View More | |
| 1110 | Osmolarity – Urine | Tat: 3 Days | View More | |
| 6051 | Pan Fungal Infectious PCR | Tat: 6 Days | View More | |
| 6055 | Pandemic H1 Influenza Virus (Swine Flu) (H1N1, H3N2) PCR | Tat: 2 Days | View More | |
| 6044 | Parvovirus B19 PCR | Tat: 5 Days | View More | |
| Assure - 24 | PCOD Profile – Glucose Fasting (F), Testosterone – Total, FSH(Follicle Stimulating Hormone), Insulin-Fasting, LH(Leutinizing Hormone)-Serum, Prolactin (PRL) | Tat: 1 Day | View More | |
| 4565 | PGDFRA | Tat: 7 Days | View More | |
| 1111 | Phosphorus | Tat: 2 Days | View More | |
| 7017 | Placental Growth Factor (PlGF) | Tat: 5 Days | View More | |
| 4521 | PML/RARA t(15,17) QUALITATIVE PCR | Tat: 3 Days | View More | |
| 4522 | PML/RARA t(15,17) QUANTITATIVE PCR | Tat: 3 Days | View More | |
| 2214 | PML/RARA t(15;17) – AML-M3 | Tat: 3 Days | View More | |
| 2019 | Prader-Willi | Tat: 5 Days | View More | |
| 4080 | Prader-Willi Syndrome | Tat: 10 Days | View More | |
| 7020 | Pre-Eclampsia (SFLT-1/PLGF Ratio) | Tat: 6 Days | View More | |
| 1508 | Progesterone | Tat: 2 Days | View More | |
| 1509 | Prolactin | Tat: 2 Days | View More | |
| 1152 | Protein – Fluids | Tat: 2 Days | View More | |
| 1153 | Protein – Random (Spot) | Tat: 2 Days | View More | |
| 1154 | Protein Total | Tat: 2 Days | View More | |
| 1155 | Protein Total with Albumin | Tat: 2 Days | View More | |
| 1156 | Protein/Creatinine Ratio | Tat: 2 Days | View More | |
| 1606 | Prothrombin Time (PT INR) | Tat: 1 Day | View More | |
| 1517 | PTH -Intact Parathyroid Hormone | Tat: 2 Days | View More | |
| 7014 | Quadruple Marker – AFP, B HCG, Estroil, Inhibin A | Tat: 3 Days | View More | |
| 1167 | RA/RF Factor | Tat: 2 Days | View More | |
| HP04 | Radical Biopsy ( Any Organ with Lymph Node ) | Tat: 6 Days | View More | |
| 2244 | RARA (17q21) – AML | Tat: 3 Days | View More | |
| 6054 | Respiratory syncytial Virus (RSV) PCR | Tat: 2 Days | View More | |
| IHC-111 | Routine Breast Carcinoma | Tat: 5 Days | View More | |
| IHC-151 | Routine Lung | Tat: 5 Days | View More | |
| 1423 | Rubella IgG | Tat: 2 Days | View More | |
| 1424 | Rubella IgM | Tat: 2 Days | View More | |
| 6029 | RUBELLA PCR | Tat: 4 Days | View More | |
| 1157 | SAAG (Serum/Ascites Albumin Gradient) | Tat: 2 Days | View More | |
| IHC-135 | SCC | Tat: 5 Days | View More | |
| 1432 | Scrub Typhus IgM | Tat: 2 Days | View More | |
| 1164 | Serum Glutamic Oxaloacetic Transaminase (SGOT) | Tat: 2 Days | View More | |
| 1163 | Serum Glutamic-Pyruvic Transaminase (SGPT) | Tat: 2 Days | View More | |
| HP01 | Small Biopsy ( <2 cm : Endoscopic, Skin true cut/FNAC etc) | Tat: 3 Days | View More | |
| IHC-146 | SmCC | Tat: 5 Days | View More | |
| IHC-153 | SmCC (lung) | Tat: 5 Days | View More | |
| 4115 | Sperm DNA Fragmentation | Tat: 5 Days | View More | |
| IHC-131 | SqIL | Tat: 5 Days | View More | |
| 2025 | SRY | Tat: 5 Days | View More | |
| MB-04 | Stool Routine Examination | Tat: 1 Day | View More | |
| 1429 | Syphilis | Tat: 2 Days | View More | |
| IHC-122 | T-Cell Lymphoma | Tat: 5 Days | View More | |
| 1525 | T3 | Tat: 2 Days | View More | |
| 1524 | T4 | Tat: 2 Days | View More | |
| 1545 | Tacrolimus | Tat: 2 Days | View More | |
| 1433 | TB Gamma Interferon – Quantiferon | Tat: 2 Days | View More | |
| 1550 | TB Gold | Tat: 2 Days | View More | |
| 2241 | TCR alpha/delta (14q11.2) | Tat: 3 Days | View More | |
| 2212 | TEL/AML1 t(12;21) – ALL | Tat: 3 Days | View More | |
| test | Tat: | View More | ||
| Test1 | Tat: | View More | ||
| 1510 | Testosterone – Free | Tat: 2 Days | View More | |
| 1511 | Testosterone – Total | Tat: 2 Days | View More | |
| Assure - 27 | Thallasemia Profile – Ferritin, Iron Profile-I, Complete Blood Count (CBC), Hemoglobin Variant Estimation by Hemoglobin Electrophoresis (HPLC) | Tat: 3 Days | View More | |
| 4121 | Thallessemia Screening (CBC, Hb Electrophorosis – HPLC) | Tat: 7 Days | View More | |
| Assure - 25 | Thyroid Profile – T3, T4, TSH | Tat: 1 Day | View More | |
| NBS-03 | TMS | Tat: 6 Days | View More | |
| NBS-05 | TMS + GCMS | Tat: 6 Days | View More | |
| 1419 | TORCH IgG | Tat: 2 Days | View More | |
| 1420A | TORCH IgG+ IgM | Tat: 2 Days | View More | |
| 1420 | TORCH IgM | Tat: 2 Days | View More | |
| 6031 | TORCH PCR | Tat: 5 Days | View More | |
| 1530 | Total B HCG | Tat: 2 Days | View More | |
| 1422 | Toxoplasma Gondii IgG | Tat: 2 Days | View More | |
| 1421 | Toxoplasma Gondii IgM | Tat: 2 Days | View More | |
| 1422A | Toxoplasma IgG+IgM | Tat: 2 Days | View More | |
| 6030 | TOXOPLASMA PCR | Tat: 4 Days | View More | |
| 7012 | Triple Marker/ IInd Trimester – AFP, B HCG, Estriol | Tat: 2 Days | View More | |
| 2238 | Trisomy 12 – CLL | Tat: 3 Days | View More | |
| 2233 | Trisomy 8 – MDS | Tat: 3 Days | View More | |
| 1527 | Trop T | Tat: 2 Days | View More | |
| 1526 | TSH | Tat: 2 Days | View More | |
| 1440 | Typhidot | Tat: 2 Days | View More | |
| 1158 | Urea | Tat: 2 Days | View More | |
| 1159 | Urea (Spot) | Tat: 2 Days | View More | |
| 1160 | Uric Acid | Tat: 2 Days | View More | |
| 1161 | Urine for Chyle | Tat: 3 Days | View More | |
| MB-03 | Urine Routine Examination | Tat: 1 Day | View More | |
| 6034 | Varicella Zoster Virus (VZV) PCR | Tat: 3 Days | View More | |
| 1434 | Varicella Zoster Virus IgM (Chicken Pox; Herpes zoster; Shingles) – Serum | Tat: 2 Days | View More | |
| 1534 | Vitamin B12 | Tat: 2 Days | View More | |
| 1535 | Vitamin D3 | Tat: 2 Days | View More | |
| 1115 | VMA (Vanillyl Mandelic Acid) | Tat: 3 Days | View More | |
| WES - S | Whole Exome Sequencing (WES) – Single | Tat: 60 Days | View More | |
| WES - T | Whole Exome Sequencing (WES) – Trio | Tat: 60 Days | View More | |
| 1445 | Widal Slide Agglutination | Tat: 1 Day | View More | |
| 2247 | XY Chimerism – Bone Marrow/Stem Cell Transplant | Tat: 3 Days | View More | |
| 4110 | Y Chromosome Microdeletion | Tat: 8 Days | View More | |
| 6066 | Zika Virus PCR | Tat: 3 Days | View More | |
| 1162 | Zinc | Tat: 3 Days | View More |
